F

FATE

Fate Therapeutics Inc

2.80

Jul 20 • 03:59PM ET +0.02 (0.54%)

2.80

Aftermarket • 07:48PM ET +0.00 (0.16%)

Healthcare Biotechnology USA Small NASD

Peers: ALLO CCCC ALXO BCYC CLLS FHTX CHRS IMRX REPL ZNTL

| Held by: VTI VXF SCHA IWC VHT PRFZ SCHB AVSC DFMC QQQS

Scroll to Statements

Index	-
Market Cap	325.78M
Enterprise Value	227.74M
Income	-129.91M
Sales	6.32M
Book/sh	1.55
Cash/sh	1.50
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	161
IPO	Oct 01, 2013

P/E	-
Forward P/E	-
PEG	-
P/S	51.55
P/B	1.81
P/C	1.86
P/FCF	-
EV/EBITDA	-
EV/Sales	36.03
Quick Ratio	5.85
Current Ratio	5.85
Debt/Eq	0.43
LT Debt/Eq	0.40
Option/Short	Yes / Yes

EPS (ttm)	-1.09
EPS next Y	-1.03
EPS next Q	-0.27
EPS this Y	5.93%
EPS next Y	4.70%
EPS next 5Y	2.41%
EPS past 3/5Y	26.67% 11.42%
Sales past 3/5Y	-58.98% -26.71%
EPS Y/Y TTM	26.97%
Sales Y/Y TTM	-52.64%
EPS Q/Q	18.19%
Sales Q/Q	-20.26%
Earnings	May 13 BMO
EPS/Sales Surpr.	7.14% -12.93%

Insider Own	5.16%
Insider Trans	-0.90%
Inst Own	60.76%
Inst Trans	3.45%
ROA	-38.01%
ROE	-55.50%
ROIC	-51.60%
Gross Margin	-97.69%
Oper. Margin	-2207.47%
Profit Margin	-2056.79%
SMA20	3.80%
SMA50	18.35%
SMA200	83.75%
Trades

Shs Outstand	116.27M
Shs Float	110.55M
Short Float	6.72%
Short Ratio	1.80
Short Interest	7.43M
52W High	3.23 -13.47%
52W Low	0.91 207.14%
Volatility	7.56% 11.53%
ATR (14)	0.26
RSI (14)	56.18
Beta	2.52
Rel Volume	0.35
Avg Volume	4.12M
Volume	1,456,549

Perf Week	-7.45%
Perf Month	42.60%
Perf Quarter	101.08%
Perf Half Y	166.19%
Perf YTD	184.45%
Perf Year	147.35%
Perf 3Y	-37.19%
Perf 5Y	-96.67%
Perf 10Y	65.38%
Recom	2.00
Target Price	5.41
Prev Close	2.78
Price	2.80
Change	0.54%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)